A detailed history of Massachusetts Financial Services CO transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 248,269 shares of VKTX stock, worth $13.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
248,269
Previous 236,601 4.93%
Holding current value
$13.3 Million
Previous $12.5 Million 25.31%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$49.84 - $70.47 $581,533 - $822,243
11,668 Added 4.93%
248,269 $15.7 Million
Q2 2024

Aug 09, 2024

SELL
$47.39 - $80.2 $2.7 Million - $4.57 Million
-56,984 Reduced 19.41%
236,601 $12.5 Million
Q1 2024

May 14, 2024

SELL
$17.4 - $94.5 $6.43 Million - $34.9 Million
-369,570 Reduced 55.73%
293,585 $24.1 Million
Q4 2023

Feb 08, 2024

BUY
$9.24 - $19.64 $6.13 Million - $13 Million
663,155 New
663,155 $12.3 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.1B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.